[go: up one dir, main page]

ES539852A0 - A NEW PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES. OF CARBAZOLONA. - Google Patents

A NEW PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES. OF CARBAZOLONA.

Info

Publication number
ES539852A0
ES539852A0 ES539852A ES539852A ES539852A0 ES 539852 A0 ES539852 A0 ES 539852A0 ES 539852 A ES539852 A ES 539852A ES 539852 A ES539852 A ES 539852A ES 539852 A0 ES539852 A0 ES 539852A0
Authority
ES
Spain
Prior art keywords
new
carbazolona
preparation
derivatives
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539852A
Other languages
Spanish (es)
Other versions
ES8609309A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848401888A external-priority patent/GB8401888D0/en
Priority claimed from GB848425959A external-priority patent/GB8425959D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8609309A1 publication Critical patent/ES8609309A1/en
Publication of ES539852A0 publication Critical patent/ES539852A0/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES539852A 1984-01-25 1985-01-25 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives Expired ES8609309A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848401888A GB8401888D0 (en) 1984-01-25 1984-01-25 Heterocyclic compounds
GB848425959A GB8425959D0 (en) 1984-10-15 1984-10-15 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
ES8609309A1 ES8609309A1 (en) 1986-07-16
ES539852A0 true ES539852A0 (en) 1986-07-16

Family

ID=26287221

Family Applications (3)

Application Number Title Priority Date Filing Date
ES539852A Expired ES8609309A1 (en) 1984-01-25 1985-01-25 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
ES548430A Expired ES8708224A1 (en) 1984-01-25 1985-10-31 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
ES556101A Expired ES8801247A1 (en) 1984-01-25 1986-06-16 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES548430A Expired ES8708224A1 (en) 1984-01-25 1985-10-31 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
ES556101A Expired ES8801247A1 (en) 1984-01-25 1986-06-16 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives

Country Status (29)

Country Link
KR (1) KR920003064B1 (en)
AT (1) AT392276B (en)
AU (1) AU579132B2 (en)
BE (1) BE901576A (en)
CA (1) CA1252793A (en)
CH (1) CH664152A5 (en)
CY (1) CY1479A (en)
CZ (1) CZ404391A3 (en)
DE (2) DE19375046I2 (en)
DK (1) DK169521B1 (en)
ES (3) ES8609309A1 (en)
FI (1) FI84349C (en)
FR (1) FR2561244B1 (en)
GB (1) GB2153821B (en)
GR (1) GR850219B (en)
HK (1) HK33189A (en)
HU (1) HU193592B (en)
IE (1) IE57809B1 (en)
IL (1) IL74165A (en)
IT (1) IT1182150B (en)
LU (2) LU85743A1 (en)
NL (2) NL190373C (en)
NO (2) NO164025C (en)
NZ (1) NZ210940A (en)
PH (1) PH22672A (en)
PT (1) PT79890B (en)
SE (1) SE460359B (en)
SG (1) SG7089G (en)
SK (1) SK404391A3 (en)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
DE3689974T2 (en) * 1985-03-14 1994-11-03 Beecham Group Plc Medicines to treat emesis.
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US5578628A (en) * 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (en) * 1986-07-30 1988-02-16 Sandoz Ag METHOD FOR THE THERAPEUTIC USE OF SEROTONIN ANTAGONISTS, ACTIVE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
JP2765845B2 (en) * 1986-11-21 1998-06-18 グラクソ、グループ、リミテッド Remedies for prevention of discontinuation syndrome
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
US5202343A (en) * 1986-11-28 1993-04-13 Glaxo Group Limited Tricyclic ketones useful as HT3 -receptor antagonists
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
GB8628475D0 (en) * 1986-11-28 1987-01-07 Glaxo Group Ltd Medicaments
DK662687A (en) * 1986-12-17 1988-06-18 Glaxo Group Ltd USE OF TRICYCLIC CARBAZOLONES
GB8630079D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8630071D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
DE3788057T2 (en) * 1986-12-17 1994-03-03 Glaxo Group Ltd Use of heterocyclic compounds for the treatment of depression.
DE3876006T2 (en) * 1987-04-14 1993-03-25 Glaxo Group Ltd KETONE DERIVATIVES.
EP0295836B1 (en) * 1987-06-16 1992-09-02 Btg International Limited Use of dioxopiperidine derivatives for the manufacture of topical medicaments as analgesics
DE3822792C2 (en) * 1987-07-11 1997-11-27 Sandoz Ag New use of 5HT¶3¶ antagonists
GB8723157D0 (en) * 1987-10-02 1987-11-04 Beecham Group Plc Compounds
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
JPH01258673A (en) * 1987-10-22 1989-10-16 Glaxo Group Ltd Ketone derivative
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
JPH0249772A (en) * 1988-04-07 1990-02-20 Glaxo Group Ltd Imidazole derivative
DK185489A (en) * 1988-04-22 1989-10-23 Duphar Int Res IMIDAZOLYLMETHYL-CYCLOALKANOEBAA INDOLONES, THEIR PREPARATION AND USE
JPH0256485A (en) * 1988-04-27 1990-02-26 Glaxo Group Ltd Lactam derivative
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
AU627221B2 (en) * 1988-09-27 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Pyridoindole derivatives and processes for preparation thereof
US5173493A (en) * 1988-09-27 1992-12-22 Fujisawa Pharmaceutical Company, Ltd. Pyridoindole derivatives and processes for preparation thereof
FR2639944B1 (en) * 1988-12-06 1991-01-18 Adir NEW INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0377238A1 (en) * 1988-12-22 1990-07-11 Duphar International Research B.V New annelated indolo (3,2-c)-lactams
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives
KR900013959A (en) * 1989-03-13 1990-10-22 원본미기재 γ-carbline or their pharmaceutically acceptable acid addition salts and / or hydrates, and pharmaceutical compositions composed thereof
DE69004924T2 (en) * 1989-04-21 1994-05-19 Sandoz Ag THERAPEUTIC USE OF 5-HT3 RECEPTOR ANTAGONISTS.
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
US5126343A (en) * 1989-09-11 1992-06-30 G. D. Searle & Co. N-azabicyclo [3.3.0]octane amides of aromatic acids
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
JPH06508836A (en) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド Methods and compositions for the treatment of emesis, nausea and other disorders using optically pure R(+) ondansetron
JPH05310732A (en) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp Cinnoline-3-carboxylic acid derivative
ES2043535B1 (en) * 1992-03-13 1994-08-01 Vita Invest Sa PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
HU212934B (en) 1992-10-14 1996-12-30 Richter Gedeon Vegyeszet Process for producing novel alkoxalylated carbazolone derivatives
AU683447B2 (en) * 1993-03-08 1997-11-13 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular diseases
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB2325409B (en) * 1994-06-28 1999-02-10 Kenneth Francis Prendergast Pharmaceutical use of ondansetron/cyclodextrin complexes
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
US6365743B1 (en) 1995-10-13 2002-04-02 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
EP1207160A1 (en) * 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
RU2207340C2 (en) * 2001-08-10 2003-06-27 Ципла Лтд. Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts
WO2003093281A1 (en) 2002-04-29 2003-11-13 Biogal Gyogyszergyar Rt. Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one
FI6164U1 (en) * 2003-01-09 2004-03-15 Synthon Bv Ondansetronformer
GB2398071B (en) * 2003-01-24 2006-06-07 Synthon Bv Process for making ondansetron and intermediate thereof
ES2238001B1 (en) * 2004-01-21 2006-11-01 Vita Cientifica, S.L. NEW POLYMORPHIC FORMS OF ONDANSETRON, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANANTIMETICS.
CA2565854A1 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
US20090170872A1 (en) * 2005-07-05 2009-07-02 Orchid Research Laboratories Limited Compounds and Their Pharmaceutical Use
ES2432618T3 (en) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of a pathology of the inner ear with vestibular deficit
KR101779991B1 (en) 2009-05-20 2017-09-19 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
CN115611864A (en) * 2022-11-01 2023-01-17 常州兰陵制药有限公司 A kind of ondansetron compound and its preparation method and application
GB202301322D0 (en) 2023-01-30 2023-03-15 Therakind Ltd Antiemetic pharmaceutical compositions for nasal delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740404A (en) * 1969-05-09 1973-06-19 American Cyanamid Co Piperidinomethylenedihydrocarbazolones
US3634420A (en) * 1969-05-09 1972-01-11 American Cyanamid Co 3(morpholinomethyl)-2 3-dihydro-carbazol-4(1h)-ones
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives

Also Published As

Publication number Publication date
NL8500202A (en) 1985-08-16
SE8500368D0 (en) 1985-01-25
ES556101A0 (en) 1987-12-16
LU88268I2 (en) 1994-02-03
SE460359B (en) 1989-10-02
KR920003064B1 (en) 1992-04-13
GB8501889D0 (en) 1985-02-27
DK169521B1 (en) 1994-11-21
SE8500368L (en) 1985-07-26
CZ404391A3 (en) 1993-04-14
FR2561244B1 (en) 1988-03-04
NO164025B (en) 1990-05-14
FI84349C (en) 1991-11-25
ES8708224A1 (en) 1987-10-01
NL940009I1 (en) 1994-07-18
AT392276B (en) 1991-02-25
SG7089G (en) 1989-06-09
FR2561244A1 (en) 1985-09-20
AU3809785A (en) 1985-08-01
NL190373C (en) 1994-02-01
FI850323L (en) 1985-07-26
GB2153821A (en) 1985-08-29
GB2153821B (en) 1988-01-20
PT79890B (en) 1987-02-03
PH22672A (en) 1988-11-14
GR850219B (en) 1985-05-23
NL940009I2 (en) 1999-05-03
AU579132B2 (en) 1988-11-17
LU85743A1 (en) 1986-08-04
HU193592B (en) 1987-11-30
SK277923B6 (en) 1995-08-09
DE3502508C2 (en) 1990-05-03
NZ210940A (en) 1989-08-29
NO850300L (en) 1985-07-26
IT8547600A0 (en) 1985-01-25
NO164025C (en) 1990-08-22
DK35785A (en) 1985-07-26
SK404391A3 (en) 1995-08-09
IE850187L (en) 1985-07-25
IT1182150B (en) 1987-09-30
ES8801247A1 (en) 1987-12-16
DE3502508A1 (en) 1985-08-14
CA1252793A (en) 1989-04-18
ES8609309A1 (en) 1986-07-16
FI850323A0 (en) 1985-01-25
CH664152A5 (en) 1988-02-15
PT79890A (en) 1985-02-01
KR850005439A (en) 1985-08-26
IL74165A (en) 1988-11-15
BE901576A (en) 1985-07-25
HK33189A (en) 1989-04-28
NL190373B (en) 1993-09-01
NO1994022I1 (en) 1994-11-09
ES548430A0 (en) 1987-10-01
DK35785D0 (en) 1985-01-25
HUT37784A (en) 1986-02-28
ATA20485A (en) 1990-08-15
DE19375046I2 (en) 2002-10-10
CY1479A (en) 1989-07-21
FI84349B (en) 1991-08-15
IE57809B1 (en) 1993-04-21

Similar Documents

Publication Publication Date Title
ES539852A0 (en) A NEW PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES. OF CARBAZOLONA.
ES544644A0 (en) A PROCEDURE FOR THE PREPARATION OF CARBOXAMIDOADENOSINE DERIVATIVES.
ES543115A0 (en) A NEW PROCEDURE FOR THE PREPARATION OF PIRIDO-IMIDAZORIFAMICINAS
ES545464A0 (en) A PROCEDURE FOR THE PREPARATION OF TETRAHIDROFTALIMIDAS.
ES540705A0 (en) A PROCEDURE FOR THE PREPARATION OF 17B-CARBAMOIL-N-MONOSUSTITUTED -O 17B-ACIL-4-AZA-5-ALFA-ANDROSTIEN-3-ONAS.
ES518225A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF OXABICICLOALCANO.
ES546236A0 (en) A PROCEDURE FOR THE PREPARATION OF BENCIMIDASOL DERIVATIVES.
ES541200A0 (en) A PROCEDURE FOR THE PREPARATION OF A DIBENZOILMETHANE DERIVATIVE.
ES540901A0 (en) A PROCEDURE FOR THE PREPARATION OF DISSTITUTED N, N-PIPERICINYL DERIVATIVES.
ES540609A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLO PIRIDINAS.
ES544521A0 (en) A PROCEDURE FOR THE PREPARATION OF TRIAZOLOBENZODIAZEFINAS.
ES546872A0 (en) A PROCEDURE FOR THE PREPARATION OF AMINOALCOXIBENZOPIRANONES.
ES540610A0 (en) A PROCEDURE FOR THE PREPARATION OF PIRAZOLOPIRIDINAS.
ES516825A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 3-AMINO-PREGN-5-ENO.
ES550504A0 (en) A PROCEDURE FOR THE PREPARATION OF PODOFILOTOXIN DERIVATIVES.
ES541781A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOTIOPENES.
ES549498A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW CEPHALOSPORIN DERIVATIVES.
ES542013A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW CEPHALOSPORIN DERIVATIVES.
ES547805A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW GUANINA DERIVATIVES.
ES539853A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW PENEM DERIVATIVES.
ES510067A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZOILUREA DERIVATIVES.
ES518975A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF 2-PIPERAZINO PRIMIDINA.
ES543116A0 (en) A NEW PROCEDURE FOR THE PREPARATION OF IMIDAZORRIFA- MICINAS
ES539543A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW OXADIAZINONE COMPOUNDS.
ES547205A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW QUINAZOLINDIONAS.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060425